Molecular basis for dramatic changes in cannabinoid CB1 G protein‐coupled receptor activation upon single and double point mutations
暂无分享,去创建一个
[1] Aashish Manglik,et al. Structure of the δ-opioid receptor bound to naltrindole , 2012, Nature.
[2] Bryan L. Roth,et al. Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic , 2012, Nature.
[3] L. Pardo,et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.
[4] R. Stevens,et al. Crystal Structure of a Lipid G Protein–Coupled Receptor , 2012, Science.
[5] R. Stevens,et al. Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.
[6] Ravinder Abrol,et al. Bihelix: Towards de novo structure prediction of an ensemble of G‐protein coupled receptor conformations , 2012, Proteins.
[7] M. Congreve,et al. Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. , 2011, Structure.
[8] S. Rasmussen,et al. Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.
[9] Ruben Abagyan,et al. Structure of the human histamine H1 receptor complex with doxepin , 2011, Nature.
[10] A. Leslie,et al. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation , 2011, Nature.
[11] Gebhard F. X. Schertler,et al. Two distinct conformations of helix 6 observed in antagonist-bound structures of a β1-adrenergic receptor , 2011, Proceedings of the National Academy of Sciences.
[12] R. Stevens,et al. Structure of an Agonist-Bound Human A2A Adenosine Receptor , 2011, Science.
[13] Gebhard F. X. Schertler,et al. The structural basis of agonist-induced activation in constitutively active rhodopsin , 2011, Nature.
[14] Oliver P. Ernst,et al. Crystal structure of metarhodopsin II , 2011, Nature.
[15] R. Abagyan,et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.
[16] Jonathan A. Javitch,et al. Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist , 2010, Science.
[17] Cheng Zhang,et al. Structure and Function of an Irreversible Agonist-β2 Adrenoceptor complex , 2010, Nature.
[18] S. Rasmussen,et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.
[19] Laurence J. Miller,et al. Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery , 2010, Pharmacological Reviews.
[20] J. Shim. Understanding Functional Residues of the Cannabinoid CB1 Receptor for Drug Discovery , 2010 .
[21] K. Ahn,et al. Dual Role of the Second Extracellular Loop of the Cannabinoid Receptor 1: Ligand Binding and Receptor Localization , 2009, Molecular Pharmacology.
[22] J. Shim,et al. Transmembrane helical domain of the cannabinoid CB1 receptor. , 2009, Biophysical journal.
[23] W. Goddard,et al. Flat-Bottom Strategy for Improved Accuracy in Protein Side-Chain Placements. , 2008, Journal of chemical theory and computation.
[24] R. Stevens,et al. The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.
[25] Oliver P. Ernst,et al. Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.
[26] Patrick Scheerer,et al. Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.
[27] Gebhard F. X. Schertler,et al. Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.
[28] Tetsuya Hori,et al. Crystal Structure of Squid Rhodopsin with Intracellularly Extended Cytoplasmic Region , 2008, Journal of Biological Chemistry.
[29] R. Stevens,et al. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. , 2008, Structure.
[30] Tsutomu Kouyama,et al. Crystal structure of squid rhodopsin , 2008, Nature.
[31] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[32] M. Burghammer,et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.
[33] Manfred Burghammer,et al. Crystal structure of a thermally stable rhodopsin mutant. , 2007, Journal of molecular biology.
[34] Tetsuji Okada,et al. Photoisomerization mechanism of rhodopsin and 9-cis-rhodopsin revealed by x-ray crystallography. , 2007, Biophysical journal.
[35] Krzysztof Palczewski,et al. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin , 2006, Proceedings of the National Academy of Sciences.
[36] Lei Wang,et al. A cannabinoid receptor 1 mutation proximal to the DRY motif results in constitutive activity and reveals intramolecular interactions involved in receptor activation , 2006, Brain Research.
[37] S. McAllister,et al. Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interaction. , 2006, Journal of medicinal chemistry.
[38] Xavier Deupi,et al. Coupling ligand structure to specific conformational switches in the β2-adrenoceptor , 2006, Nature chemical biology.
[39] K. Ahn,et al. Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization. , 2006, Biochemistry.
[40] Viktor Hornak,et al. Location of Trp265 in metarhodopsin II: implications for the activation mechanism of the visual receptor rhodopsin. , 2006, Journal of molecular biology.
[41] Marc A. Martí-Renom,et al. MODBASE: a database of annotated comparative protein structure models and associated resources , 2005, Nucleic Acids Res..
[42] Marcus Elstner,et al. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. , 2004, Journal of molecular biology.
[43] Manfred Burghammer,et al. Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.
[44] Mary E Abood,et al. An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region. , 2003, Journal of medicinal chemistry.
[45] Z. H. Song,et al. Effects of D3.49A, R3.50A, and A6.34E mutations on ligand binding and activation of the cannabinoid-2 (CB2) receptor. , 2003, Biochemical pharmacology.
[46] D. Lynch,et al. N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor. , 2002, Molecular pharmacology.
[47] F Guarnieri,et al. Activation of the cannabinoid CB1 receptor may involve a W6 48/F3 36 rotamer toggle switch. , 2002, The journal of peptide research : official journal of the American Peptide Society.
[48] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[49] Yoshinori Shichida,et al. Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. Ballesteros,et al. Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6* , 2001, The Journal of Biological Chemistry.
[51] D C Teller,et al. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). , 2001, Biochemistry.
[52] K. Palczewski,et al. X-Ray diffraction analysis of three-dimensional crystals of bovine rhodopsin obtained from mixed micelles. , 2000, Journal of structural biology.
[53] Z. Vogel,et al. Role of the highly conserved Asp‐Arg‐Tyr motif in signal transduction of the CB2 cannabinoid receptor , 2000, FEBS letters.
[54] J. Pierce,et al. Crystallization and characterization of bovine liver glutamate dehydrogenase. , 1997, Journal of structural biology.
[55] T. Creamer,et al. Solvation energies of amino acid side chains and backbone in a family of host-guest pentapeptides. , 1996, Biochemistry.
[56] S. L. Mayo,et al. DREIDING: A generic force field for molecular simulations , 1990 .
[57] Z. Benyó,et al. Effects of D3 , 2013 .
[58] W. Goddard,et al. Structure prediction of G protein-coupled receptors and their ensemble of functionally important conformations. , 2012, Methods in molecular biology.
[59] R. Stevens,et al. Structure of the human k-opioid receptor in complex with JDTic , 2012 .
[60] M. Burghammer,et al. Crystal structure of the human b 2 adrenergic G-protein-coupled receptor , 2007 .
[61] A. Sali,et al. Modeller: generation and refinement of homology-based protein structure models. , 2003, Methods in enzymology.
[62] J. Ballesteros,et al. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .
[63] Clare E. M. Stevenson,et al. Structural Biology and Crystallization Communications Crystallization and Preliminary X-ray Analysis of the O-methyltransferase Novp from the Novobiocin- Biosynthetic Cluster of Streptomyces Spheroides , 2007 .